- £498.11m
- £574.78m
- £166.60m
- 81
- 31
- 97
- 83
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 110 | 120 | 128 | 139 | 167 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 97 | 106 | 115 | 120 | 144 |
Operating Profit | 12.9 | 13.4 | 13.2 | 19 | 22.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 11.4 | 11.1 | 11.4 | 16.9 | 19.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 10.4 | 7.4 | 8.96 | 9.42 | 15.8 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 11.5 | 7.4 | 8.96 | 9.42 | 15.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 11.5 | 7.4 | 8.96 | 9.42 | 15.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.068 | 0.053 | 0.065 | 0.029 | 0.099 |
Dividends per Share |